Dr. Stanley Marks, MD is the ​Chairman of UPMC's Hillman Cancer Center, the Chief of the Division of Hematology-Oncology at UPMC Shadyside, and a Clinical Professor of Medicine at the University of Pittsburgh. Dr. Marks is a world-recognized leader in cancer research having served as President of The Leukemia & Lymphoma Society and on the board of directors of the American Cancer Society, among others. He is also a leading clinician and noted advocate for patients. He is consistently listed among the “Best Cancer Doctors in America” and his patients have founded the Dr. Stanley Marks Research Endowed fund at the Hillman Cancer Center which has raised $7 million for cancer research to date. Dr. Marks has served as chairman of the board at multiple oncology companies including Via Oncology, CTS International and CytoAgents.​